Stanford University
Showing 541-560 of 831 Results
-
Anna Maria Bombardieri
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsMy overall research goal is to advance clinical practice by providing anesthesiologists with data to most effectively maintain cerebral blood flow in the perioperative period.
I am interested in the effect of the autonomic nervous system on cerebral blood flow regulation.
I intend to combine regional anesthetic techniques and noninvasive bedside cerebral blood flow monitoring to understand the effect of the sympathetic system on cerebral blood flow.
A secondary goal is to apply this new knowledge to investigate whether cervical sympathetic blocks improve long term neurological outcomes. -
Serena Bonaretti
Physical Science Research Scientist, Rad/Musculoskeletal Imaging
BioPlease visit My Personal Site and the JOINT Group Website (Links on the right)
-
Melissa L Bondy
Stanford Medicine Discovery Professor, Professor of Epidemiology and Population Health and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsPrincipal Investigator, Discovery, Biology and Risk of Inherited Variants in Glioma, 1R01CA217105-01A1, NIH/NCI, 05/01/2018-06/30/2022, MPI (Contact PI)
Principal Investigator, Characterizing Germline and Somatic Alterations by Glioma Subtypes and Clinical Outcome, 1R01CA232754-01, 07/01/2019-06/30/2023, MPI (Contact PI)
Co-Leader (Project), SPORE in Brain Cancer, PI – Fred Lang (Sub with MD Anderson), 2 P50CA127001-11, 09/01/2019-08/31/2023
Co-Investigator, Stanford University Cancer Center, PI – Steve Artandi, P30 CA124435, NCI, 09/15/10-05/31/22
Co-Investigator, Ovarian Cancer Survival in African-American Women, PI, Joellen Schildkraut, R01 CA237318-01A1, NIH/NCI, 07/01/2020-06/31/2025 -
C. Andrew Bonham, MD, FACS
Associate Professor of Surgery (Abdominal Transplantation), Emeritus
Current Research and Scholarly InterestsTolerance induction in liver transplantation.
Hepatocyte transplantation. -
Bernardo Bonilauri
Postdoctoral Scholar, Cardiovascular Institute
BioI am a highly motivated and devoted scientist, deeply committed to advancing our understanding of the molecular foundations of cardiovascular disease while spearheading innovative therapeutic approaches and drug discovery. As a Postdoctoral Research Fellow at the Stanford Cardiovascular Institute, under the guidance of Dr. Joseph C. Wu, I am privileged to contribute to cutting-edge research. My work spans various disciplines, including multi-omics, molecular and cellular biology, tissue engineering, biochemistry, structural biology, and state-of-the-art imaging technologies. This holistic approach and sharp critical thinking equips me to untangle the complexities of cardiac diseases and innovate novel therapeutic strategies, particularly for rare cardiac conditions such as Transthyretin Cardiac Amyloidosis.
-
Hector Fabio Bonilla
Clinical Associate Professor, Medicine - Infectious Diseases
BioAs a young physician at Louisiana State University, Dr. Bonilla focused on the Clinical Management of HIV/AIDS and HCV, two neglected and stigmatized diseases for which effective therapies were in their infancy. While learning the clinical aspects of the two diseases, Dr. Bonilla saw a need to create and organize a support community to promote understanding and management of the conditions. Subsequently, he went to Summa Health System in Akron, Ohio, and he continued his work where he specialized in HIV/HCV as well as in Infectious Diseases Clinical Practice. In addition to teaching medical residents and students, Dr. Bonilla participated in numerous clinical trials and developed clinical research projects. Furthermore, he led the Infection Renal Transplant Program, HIV and HCV clinics, and he participated in several cooperative studies with Case Western Reserve University. Dr. Bonilla’s interest in academia led him to the University Of Pittsburgh Medical Center where he was an Assistant Professor, Clinician, and Medical Educator in the Department of Medicine in the Division of Infectious Diseases. Due to his interest in cytokines and immunological responses, Dr. Bonilla became a researcher at ImmunoScience Inc., a biotechnology company in California that works to develop a therapeutic HIV vaccine. Dr. Bonilla’s experience of treating HIV/HCV combined with his interest in inflammatory response is the driving force behind his desire to understand ME/CFS. Dr. Bonilla is a strong patient advocate, and he believes in integrated care—care in which physicians communicate and coordinate efforts to deliver the best medical outcome for patients. His ME/CFS patients are his inspiration, and he is committed to continuing research to seek answers to their health challenges.
-
Anna Booman
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioAnna Booman, PhD, MS is a Postdoctoral Scholar in the Department of Anesthesiology, Perioperative, and Pain Medicine. She is also affiliated with the Dunlevie Maternal-Fetal Medicine Center for Discovery, Innovation, and Clinical Impact. She conducts perinatal pharmacoepidemiology research through the use of large observational datasets, such as the Merative MarketScan Database, and complex epidemiologic methods.
Dr. Booman received her BS in Mathematical Biology (minor: Computer Science) from the College of William & Mary, her MS in Computational Biology & Quantitative Genetics from the Harvard T.H. Chan School of Public Health, and her PhD in Epidemiology from the Oregon Health & Science University School of Public Health. Her research has spanned many areas of perinatal epidemiology, including a focus on twin gestations, rare genetic disorders, gestational weight gain, and insurance discontinuity in pregnancy. -
John Boothroyd
Burt and Marion Avery Professor of Immunology, Emeritus
Current Research and Scholarly InterestsWe are intereseted in the interaction between the protozoan parasite Toxoplasma gondii and its mammalian host. We use a combination of molecular and genetic tools to understand how this obligate intracellular parasite can invade almost any cell it encounters, how it co-opts a host cell once inside and how it evades the immune response to produce a life-long, persistent infection.
